Aptamer-functionalized Hybrid Nanoparticles to Enhance the Delivery of Doxorubicin into Breast Cancer Cells by Silencing P-glycoprotein

OBJECTIVE: The MDR of metastatic breast cancer cells is accompanied by the overexpression of P-gp transporter. This study has been focused to determine whether silencing the expression of P-gp by aptamer-labeled siRNA nanoparticles could enhance the delivery of doxorubicin into breast cancer cells i...

Descripción completa

Detalles Bibliográficos
Autores principales: Chandra, Sruti, Michael Nguyen, Hoang, Wiltz, Kylar, Hall, Nicholas, Chaudhry, Shanzay, Olverson, George, Mandal, Tarun, Dash, Srikanta, Kundu, Anup
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213597/
https://www.ncbi.nlm.nih.gov/pubmed/32395707
http://dx.doi.org/10.29245/2578-2967/2020/1.1176

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213597/
https://www.ncbi.nlm.nih.gov/pubmed/32395707
http://dx.doi.org/10.29245/2578-2967/2020/1.1176

Ejemplares similares